Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Aging and Health
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Berg, S.
Right arrow Articles by Dellasega, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, S.
Right arrow Articles by Dellasega, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Use of Psychoactive Medications and Cognitive Function in Older Adults

Stig Berg, PhD

University College of Health Sciences

Cheryl Dellasega, GNP, PhD

Pennsylvania State University

This study examined the relationship between cognitive function and psychotropic medication use in a population sample (n = 743) of elderly persons. Approximately one third of subjects received such agents, which consisted primarily of anxiolytics, hypnotics, and antidepressants. Subjects received a battery of cognitive tests at three time points: when they were 70, 75, and 79 years of age. Data on medication use revealed that the use of psychoactive agents increased with age, and was greater for females. A cross-sectional analysis showed that those using psychoactive medicines had lower cognitive test scores compared with those who did not receive such drugs. Repeated measures analysis of variance demonstrated that psychotropics had a negative and cumulative effect on cognition, with the function of subjects who received psychoactive agents consistently poorer than those who did not. The magnitude of this effect is relatively small and for several cognitive tests subjects who received these drugs averaged only a few points lower than individuals not using psychoactive medicines.

Journal of Aging and Health, Vol. 8, No. 1, 136-149 (1996)
DOI: 10.1177/089826439600800107
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Geriatr Psychiatry NeurolHome page
J. O. Brooks and J. C. Hoblyn
Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults
J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 199 - 214.
[Abstract] [PDF]